BOSTON, April 23 Here are today's highlights from the AACE Annual Meeting & Clinical Congress in Boston:
New Research Indicates a Massive Underdiagnosis of Obesity when Using Body Mass Index (BMI)
A retrospective analysis of 1,234 Americans indicated a substantial underdiagnosis of obesity when Body Mass Index (BMI) was used compared to the Dual Energy X-ray Absorptiometry (DEXA) scan. Click here to read the press release.
Endocrine Intervention in Surgical Patients with Diabetes Leads to Shorter Hospital Stays, Reduced Costs
New research released today indicates that endocrine intervention in surgical patients with diabetes and dysglycemia (abnormal blood sugar) accounted for shorter hospital stays and a decrease in the expense of treating these patients. Click here to read the press release.
New Data Questions Whether Diabetes Is Really "Cured" by Gastric Bypass Surgery
A new case study cautioned against promoting gastric bypass surgery as a "cure" for diabetes at the AACE 19th Annual Meeting & Clinical Congress in Boston today. The study cited that normal hemoglobin A1C (HbA1C) and fasting blood glucose (FBG) were insufficient criteria for such a determination. Click here to read the press release.
American College of Endocrinology (ACE) and Lilly Diabetes Create Free Checklist to Help Diabetes Patients Prepare Before Disaster Strikes
Disasters can strike at a moment's notice, often with little or no warning. Diabetes patients are much more susceptible to illness in these types of situations. Early preparation is essential. That is why the American College of Endocrinology (ACE) and Lilly Diabetes have created the "Power of Prevention: Diabetes Disaster Plan." Click here to read the press release.
American Association of Clinical Endocrinologists to Focus on POEMs in Clinical Practice Guideline Development
The American Association of Clinical Endocrinologists (AACE) today released the Protocol for Standardized Production of Clinical Practice Guidelines - 2010 Update. This protocol is designed to ensure that all subsequent clinical practice guidelines meet not only Evidence Based Medicine (EBM) standards, but also incorporate subjective factors that can improve patient outcomes. This protocol is an update of the first AACE guidelines for guidelines, published in 2004. In total, AACE has published 17 Clinical Practice Guidelines, nine of those have been published since 2004. Guidelines currently under development, which will adhere to the new protocol, will address hypothyroidism, osteoporosis, and acromegaly. Click here to read the press release.
Additional data issued at the AACE 19th Annual Meeting and Clinical Congress:
New Data Demonstrate Welchol® (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients with High LDL Cholesterol and Prediabetes: Click here to read the press release.
Follow-up Safety Data Show AFREZZA(TM) Comparable to Standard Antidiabetic Therapy in Lung Function Tests: Click here to read the press release.
Study Shows AFREZZA(TM) Controls Blood Sugar Levels in Type 1 Diabetes, Results in Weight Loss, Less Hypoglycemia Than Usual Care: Click here to read the press release.
About the American Association of Clinical Endocrinologists (AACE)
AACE is a professional medical organization with more than 6,000 members in the United States and 91 other countries. AACE members are physicians who specialize in endocrinology, diabetes, and metabolism. For more information about AACE, visit our Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow us on Twitter at www.twitter.com/theaace.
SOURCE American Association of Clinical Endocrinologists